StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
Illumina
137.99
-1.79%
 

ILMN

 

Illumina

$ 137.99

 
-$2.51 | -1.79%
 
 
Open
$ 140.25
 
 
MKT CAP
$ 21.93B
 
High
$ 140.80
 
 
VOL
$ 508.70K
 
Low
$ 135.92
 
 
AVG VOL
$ 1.77M
 
 
 

ILMN Stock Analysis

  Login to display Illumina (ILMN) recommendation from the last 90 days from financial news and social media.
 
 

ILMN Total Score

 
 

Strengths

ILMN Rewards

 Earnings are forecast to grow

ILMN Rewards

 Investors confidence is positive

ILMN Rewards

 Analysts raised price target

ILMN Rewards

 Outperform the market

 
 

Chart

 
 

138.88

113.99

119.64

202.59

 
 
1month
3month
6month
1year
 
Total Return
ILMN
vs.
S&P500
 

 
1-week Return
-1.05%
 
+1.38%
 
 
5-week Return
-1.66%
 
+5.26%
 
 
10-week Return
-0.89%
 
+7.96%
 
 
 

ILMN Risk Level

This Indicator assigning ILMN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
ILMN Risk Level
LOW
HIGH

Risk Volatility

 

ILMN has Low Risk Level

Click here to check what is your level of risk

 

ILMN Analysts Opinion

ILMN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 

ILMN Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

3.50
 
 

Momentum

×
 

Momentum

3.10
 

ILMN Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

3.88
 

ILMN Activity Sentiment

 Investors confidence is positive

ILMN Activity Sentiment

 Insider buying over the past 3 months

 

Future

×
 

Future

3.67
 

ILMN Future Sentiment

 Earnings are forecast to grow

ILMN Future Sentiment

 Analysts raised price target

ILMN Future Sentiment

 Outperform the market

 
 

ILMN Analysts Opinion

ILMN Analysts opinion is positive and also has improved from the past 3 months

 

ILMN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
 
50%
50%
78%
 
On Track
On Track
On Track
 

ILMN Street Opinion 

ILMN Street view is extremely ish and have positive views on the near-term outlook

 

ILMN Performance Sentiment

Sentiments overview associated with ILMN events and the stock performance.
 
78%
17%
Positive
Negative
32 out of 41
events present
7 out of 41
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

ILMN Earnings

The TTM reflects 12-month period, providing review of ILMN financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
4,465
4,584
4,526
-0.68%
 
 
Cost of Revenue
1,723
1,612
1,372
+12.06%
 
 
Gross Profit
2,742
2,972
3,154
-6.76%
 
 
Operating Exp
2,918
2,618
3,277
-5.64%
 
 
Operating Inc
-176
354
-123
-
 
 
Net Interest Inc
-14
-15
-61
-
 
 
Interest Exp
68
26
61
+5.58%
 
 
Interest Inc
54
11
-
 
 
Other Income
-928
-4,675
1,068
 
 
EPS
-7.10
-28.00
5.07
 
 
Next Earnings Date: Apr 23, 2024
 
 
Highlights
Last Modify
Price
% Change

 
Investors Buying
This Week
140.98
+0.87%
 
HR Activity
This Week
136.97
+2.98%
 
Strong Earnings
3 Weeks Ago
137.84
-3.83%
 
Strong Earnings
3 Weeks Ago
143.33
+0.27%
 
Price Target Reached
2 Month Ago
147.20
+0.33%
 
 
 
joker
 
 
 
StocksRunner

Explore our ILMN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ILMN Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

ILMN Rewards

 Earnings are forecast to grow

ILMN Rewards

 Investors confidence is positive

ILMN Rewards

 Analysts raised price target

ILMN Rewards

 Outperform the market

 
 
 

ILMN Risk Level

 
 
 

The Indicator assigning ILMN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
ILMN Risk Level
LOW
HIGH

Risk Volatility

 

ILMN has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

ILMN

 

Illumina

$ 137.99

 
-$2.51 | -1.79%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 140.25
 
 
MKT CAP
$ 21.93B
 
High
$ 140.80
 
 
VOL
$ 508.70K
 
Low
$ 135.92
 
 
AVG VOL
$ 1.77M
 
 
 

ILMN Analysis

  Sign in to view Illumina (ILMN) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

138.88

113.99

119.64

202.59

 
 
1month
3month
6month
1year
 
Total Return
ILMN
vs.
S&P500
 

 
1-week Return
-1.05%
 
+1.38%
 
 
5-week Return
-1.66%
 
+5.26%
 
 
10-week Return
-0.89%
 
+7.96%
 
 
 

ILMN Analysts Opinion

ILMN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 

ILMN Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

3.50
 
 

Momentum

×
 

Momentum

3.10
 

ILMN Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

3.88
 

ILMN Activity Sentiment

 Investors confidence is positive

ILMN Activity Sentiment

 Insider buying over the past 3 months

 

Future

×
 

Future

3.67
 

ILMN Future Sentiment

 Earnings are forecast to grow

ILMN Future Sentiment

 Analysts raised price target

ILMN Future Sentiment

 Outperform the market

 
 

ILMN Analysts Opinion

ILMN Analysts opinion is positive and also has improved from the past 3 months

 

ILMN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
 
50%
50%
78%
 
On Track
On Track
On Track
 

ILMN Street Opinion 

ILMN Street view is extremely ish and have positive views on the near-term outlook

 
ILMN Performance Sentiment
Sentiments overview associated with ILMN events and the stock performance.
 
78%
17%
Positive
Negative
32 out of 41
events present
7 out of 41
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

ILMN Earnings

The TTM data reflects the most recent 12-month period, providing overview of ILMN financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
4,465
4,584
4,526
-0.68%
 
 
Cost of Revenue
1,723
1,612
1,372
+12.06%
 
 
Gross Profit
2,742
2,972
3,154
-6.76%
 
 
Operating Exp
2,918
2,618
3,277
-5.64%
 
 
Operating Inc
-176
354
-123
-
 
 
Net Interest Inc
-14
-15
-61
-
 
 
Interest Exp
68
26
61
+5.58%
 
 
Interest Inc
54
11
-
 
 
Other Income
-928
-4,675
1,068
 
 
EPS
-7.10
-28.00
5.07
 
 
Next Earnings Date: Apr 23, 2024
 
Highlights
Last Modify
Price
% Change

 
Investors Buying
This Week
140.98
+0.87%
 
HR Activity
This Week
136.97
+2.98%
 
Strong Earnings
3 Weeks Ago
137.84
-3.83%
 
Strong Earnings
3 Weeks Ago
143.33
+0.27%
 
Price Target Reached
2 Month Ago
147.20
+0.33%
 
 
ILMN Latest News Feed

Illuminas Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides.

Wed Feb 28, 2024

Activity

Why Illumina Stock Mashed the Market on Monday. Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday with its share-price rise convincingly beating the S&.P 500 index. Investors were cheered by a stock buy

Mon Feb 26, 2024

Momentum

Monday 2/26 Insider Buying Report: ILMN MBUU. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.

Mon Feb 26, 2024

Activity
Momentum

Illumina (ILMN) Price Target Increased by 11.08% to 157.47. The average one-year price target for Illumina (NasdaqGS:ILMN) has been revised to 157.47 / share. This is an increase of 11.08% from the prior estimate of 141.77 da

Sat Feb 24, 2024

Potential

Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe. Illumina ILMN possesses promising opportunities to advance the next-generation sequencing ecosystem. Adverse macroeconomic chall

Tue Feb 20, 2024

Activity
Momentum
Momentum
Potential

Critical Insights From Illumina Analyst Ratings: What You Need To Know. Across the recent three months 8 analysts have shared their insights on Illumina (NASDAQ:) expressing a variety of opinions spanning from ish to bearish. The following table summariz

Wed Feb 14, 2024

Potential

illumina (ilmn) q4 earnings surpass estimates margin down. illumina inc. ilmn reported fourth-quarter 2023 adjusted earnings per share (eps) of 14 cents beating the zacks consensus estimate of

Fri Feb 9, 2024

Earnings

illumina forecasts flat 2024 sales as sluggish demand drags on. illumina on thursday forecast its annual core business revenue to be nearly flat compared to fiscal year 2023 as subdued demand for its genetic testing tools and diagnostics product

Thu Feb 8, 2024

Momentum

illumina beats top-line and bottom-line estimates. initiates fy24 outlook.

Thu Feb 8, 2024

Earnings

illumina earnings beat by $0.13 revenue topped estimates.

Thu Feb 8, 2024

Earnings

agree to purchase illumina at $90 earn 10.1% using options. investors eyeing a purchase of illumina inc (symbol: ilmn) shares but tentative about paying the going market price of $143.56/share might benefit from considering selling puts amon

Wed Feb 7, 2024

Activity
Potential

ilmn crosses above average analyst target. in recent trading shares of illumina inc (symbol: ilmn) have crossed above the average analyst 12-month target price of $144.68 changing hands for $146.72/share. when a stock reaches the target an anal

Tue Jan 30, 2024

Potential
Potential
Rating

monday sector leaders: healthcare utilities. in afternoon trading on monday healthcare stocks are the best performing sector higher by 0.5%. within the sector moderna inc (symbol: mrna) and illumina inc (symbol: ilmn) are two of the days st

Mon Jan 29, 2024

Potential

(ilmn) - analyzing illuminas short interest. ) short percent of float has risen 8.97% since its last report. the company recently reported that it has

Fri Jan 26, 2024

Momentum

illumina: one of the most hated stocks in healthcare is looking like a strong buy.

Mon Jan 22, 2024

Rating

illumina (ilmn) shares down 1.2% post preliminary q4 results. illumina inc. ilmn announced preliminary financial results for fourth-quarter and full-year 2023 on jan 9. following this release s

Tue Jan 16, 2024

Momentum

concentric by ginkgo and illumina join hands for pathogen monitoring programs.

Tue Jan 16, 2024

Activity

thursday sector leaders: healthcare technology & communications. the best performing sector as of midday thursday is the healthcare sector losing just 0.1%. within that group illumina inc (symbol: ilmn) and vertex pharmaceuticals inc. (symb

Thu Jan 11, 2024

Potential

tuesday sector leaders: healthcare technology & communications. in afternoon trading on tuesday healthcare stocks are the best performing sector up 0.4%. within that group catalent inc (symbol: ctlt) and illumina inc (symbol: ilmn) are two

Tue Jan 9, 2024

Potential

nasdaq 100 movers: chtr ilmn. in early trading on tuesday shares of illumina topped the list of the days best performing components of the nasdaq 100 index trading up 4.8%. year to date illumina inc registers a 0.6% gain.

Tue Jan 9, 2024

Momentum

illumina to present at j.p. morgan healthcare conference. webcast at 12:00 pm et. (rttnews) - illumina inc. (ilmn) will present at the 42nd annual j.p. morgan healthcare conference.

Tue Jan 9, 2024

Activity

illumina expects q4 revenue better than view. stock up. (rttnews) - illumina inc. (ilmn) tuesday reported its preliminary fourth-quarter and fiscal-year revenue which was higher than analysts estimate. following this announcement illuminas stock

Tue Jan 9, 2024

Momentum

illumina unveils preliminary fourth-quarter revenue that tops estimates.

Tue Jan 9, 2024

Activity

why illumina rallied 36.6% in december. shares of gene sequencing leader illumina (nasdaq: ilmn) rallied 36.6% in december according to data from s&.p global market intelligence.

Tue Jan 9, 2024

Momentum

illumina (ilmn) extends partnership to advance cancer test. illumina inc. ilmn recently entered into an agreement with janssen research &. development llc (janssen) to develop its novel mole

Mon Jan 8, 2024

Activity

ilmn final deadline alert: rosen a leading law firm encourages illumina inc. investors to secure counsel before important january 9 deadline in securities class action – ilmn. new york jan. 05 2024 (globe newswire) -- ) between may 1 2023 and octobe

Fri Jan 5, 2024

Activity

illuminas mrd technology for cancer testing collaborates with johnson & johnson unit. illumina inc. ilmn announced it has signed an agreement with janssen research &. development a unit of johnson &. johnson jnj. this collaboration will be the first

Fri Jan 5, 2024

Activity

illumina collaborates with janssen to develop mrd cancer test. (rttnews) - illumina inc. (ilmn) a dna sequencing and array-based technologies firm friday announced that it has signed an agreement with janssen research and development llc to deve

Fri Jan 5, 2024

Activity

 
 
 
 
 

Score Tracker

 
 
 
Based on 41 events in the last 90 days from financial news and social media. Last updated Mar 4, 2024 15:17 Wall St. time
 
 

ILMN Total Score

 
 
 
 
 
 
 
StocksRunner

Discover ILMN Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of ILMN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ILMN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ILMN Stock trends

ILMN Stock performance

ILMN Stock analysis

ILMN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker